🔎 Trials Near Me

Home › Kanser sa Pantog › Maryland

Pag-aaral pangklinika para sa Kanser sa Pantog sa Maryland

36 pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa mga site sa Maryland.

Mga Lungsod sa Maryland

Opisyal na teksto ng pag-aaral (English)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • National Institutes of Health Clinical Center, Bethesda
  • FMH James M Stockman Cancer Institute, Frederick
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03866382

Evaluation for NCI Surgery Branch Clinical Research Protocols

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00001823

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

  • Johns Hopkins Hospital, Baltimore
  • Johns Hopkins Hospital, Baltimore
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07225205

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  • Johns Hopkins University ( Site 0843), Baltimore
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07419295

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT00026884

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Walter Reed National Military Medical Center, Bethesda
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06995898

Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy

  • Johns Hopkins Hospital, Baltimore
Nagre-recruit
Edad 18 pataas · Kalalakihan · Na-update Nob 4, 2026 · NCT05792722

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Medical Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
  • at 10 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Johns Hopkins Kimmel Cancer Center, Baltimore
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05614739

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

  • Johns Hopkins University School of Medicine, Baltimore
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06525571

En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT04235764

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06503146

Gender Related Coping and Survivorship for Genitourinary Cancers

  • Johns Hopkins Hospital, Baltimore
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Okt 29, 2026 · NCT05649306

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Johns Hopkins University, Baltimore
  • Maryland Oncology Hematology, PA, Rockville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06172478

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT04923178

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT02379429

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
  • Johns Hopkins Hospital, Baltimore
  • at 2 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Johns Hopkins Hospital, Baltimore
  • James M Stockman Cancer Institute, Frederick
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07218380

Measuring Surgical Recovery After Radical Cystectomy

  • John Hopkins Medical Institutions, Baltimore
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT03193970

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • FMH James M Stockman Cancer Institute, Frederick
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07000084

DK222 Study at Hopkins

  • Johns Hopkins Hospital, Baltimore
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07140315

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Anne Arundel Urology, Annapolis
  • Chesapeake Urology Research Associates, Hanover
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06567743

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • National Institutes of Health, Bethesda
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • John Hopkins Hospital, Baltimore
  • Chesapeake Urology Research Associates, Hanover
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT04752722

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

  • Johns Hopkins Hospital, Baltimore
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • The John Hopkins Hospital, Baltimore
  • Maryland Oncology Hematology- Columbia, Rockville
Nagre-recruitPhase 2
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

  • Chesapeake Urology Research Associates, Hanover
Nagre-recruit
Edad 18 hanggang 88 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06394869

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Frederick Health Hospital, Frederick
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07327489

Integrated Cancer Repository for Cancer Research

  • Northwest Hospital, Randallstown
  • William E. Kahlert Regional Cancer Center, Westminster
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT05312671

Bladder EpiCheck Product Development Study

  • Chesapeake Urology Research Associates, Towson
Nagre-recruitObservasyonal na pag-aaral
Edad 22 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT07514143

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

  • Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT06778863

Renal Retention in High Grade Upper Tract Urothelial Cancer

  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT05656235

Blue Light Cystoscopy With Cysview® Registry

  • Johns Hopkins Medicine, Baltimore
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT02660645

Image-Guided Gynecologic Brachytherapy

  • The SKCCC at Johns Hopkins, Baltimore
Nagre-recruit
Edad 18 hanggang 100 · Kababaihan · Na-update Dis 18, 2025 · NCT02993900

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Bethesda
  • Massive Bio SYNERGY-AI site, Silver Spring
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.